These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31244615)

  • 21. The calcineurin inhibitor Sarah (Nebula) exacerbates Aβ42 phenotypes in a Drosophila model of Alzheimer's disease.
    Lee S; Bang SM; Hong YK; Lee JH; Jeong H; Park SH; Liu QF; Lee IS; Cho KS
    Dis Model Mech; 2016 Mar; 9(3):295-306. PubMed ID: 26659252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amyloid beta peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures.
    Zheng WH; Bastianetto S; Mennicken F; Ma W; Kar S
    Neuroscience; 2002; 115(1):201-11. PubMed ID: 12401334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathological changes induced by Alzheimer's brain inoculation in amyloid-beta plaque-bearing mice.
    Lam S; Hérard AS; Boluda S; Petit F; Eddarkaoui S; Cambon K; ; Picq JL; Buée L; Duyckaerts C; Haïk S; Dhenain M
    Acta Neuropathol Commun; 2022 Aug; 10(1):112. PubMed ID: 35974399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Eph/ephrin signalling and human Alzheimer's disease-associated EphA1 on Drosophila behaviour and neurophysiology.
    Buhl E; Kim YA; Parsons T; Zhu B; Santa-Maria I; Lefort R; Hodge JJL
    Neurobiol Dis; 2022 Aug; 170():105752. PubMed ID: 35569721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of active Aβ immunotherapy on neurons in human Alzheimer's disease.
    Paquet C; Amin J; Mouton-Liger F; Nasser M; Love S; Gray F; Pickering RM; Nicoll JA; Holmes C; Hugon J; Boche D
    J Pathol; 2015 Apr; 235(5):721-30. PubMed ID: 25430817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tau Proteins and Tauopathies in Alzheimer's Disease.
    Chong FP; Ng KY; Koh RY; Chye SM
    Cell Mol Neurobiol; 2018 Jul; 38(5):965-980. PubMed ID: 29299792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A physically-modified saline suppresses neuronal apoptosis, attenuates tau phosphorylation and protects memory in an animal model of Alzheimer's disease.
    Modi KK; Jana A; Ghosh S; Watson R; Pahan K
    PLoS One; 2014; 9(8):e103606. PubMed ID: 25089827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of tau protein in Alzheimer's disease: The prime pathological player.
    Muralidar S; Ambi SV; Sekaran S; Thirumalai D; Palaniappan B
    Int J Biol Macromol; 2020 Nov; 163():1599-1617. PubMed ID: 32784025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Miro, a Rho GTPase genetically interacts with Alzheimer's disease-associated genes (
    Panchal K; Tiwari AK
    Biol Open; 2020 Sep; 9(9):. PubMed ID: 32747449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging.
    Maass A; Lockhart SN; Harrison TM; Bell RK; Mellinger T; Swinnerton K; Baker SL; Rabinovici GD; Jagust WJ
    J Neurosci; 2018 Jan; 38(3):530-543. PubMed ID: 29192126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNT1 Downregulation and Increased Ethanol Sensitivity in Transgenic Drosophila Models of Alzheimer's Disease.
    Nikookar H; Haddadi M; Haghi M; Masoudi R
    Arch Gerontol Geriatr; 2021; 94():104355. PubMed ID: 33550108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amyloid-beta and phosphorylated tau in post-mortem Alzheimer's disease retinas.
    den Haan J; Morrema THJ; Verbraak FD; de Boer JF; Scheltens P; Rozemuller AJ; Bergen AAB; Bouwman FH; Hoozemans JJ
    Acta Neuropathol Commun; 2018 Dec; 6(1):147. PubMed ID: 30593285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroprotective Effects of PARP Inhibitors in
    Maggiore A; Casale AM; Toscanelli W; Cappucci U; Rotili D; Grieco M; Gagné JP; Poirier GG; d'Erme M; Piacentini L
    Cells; 2022 Apr; 11(8):. PubMed ID: 35455964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuronal-Derived EV Biomarkers Track Cognitive Decline in Alzheimer's Disease.
    Eren E; Leoutsakos JM; Troncoso J; Lyketsos CG; Oh ES; Kapogiannis D
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Linking aβ42-induced hyperexcitability to neurodegeneration, learning and motor deficits, and a shorter lifespan in an Alzheimer's model.
    Ping Y; Hahm ET; Waro G; Song Q; Vo-Ba DA; Licursi A; Bao H; Ganoe L; Finch K; Tsunoda S
    PLoS Genet; 2015 Mar; 11(3):e1005025. PubMed ID: 25774758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer's disease.
    Kazim SF; Iqbal K
    Mol Neurodegener; 2016 Jul; 11(1):50. PubMed ID: 27400746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drosophila models of Alzheimer's disease: advances, limits, and perspectives.
    Bouleau S; Tricoire H
    J Alzheimers Dis; 2015; 45(4):1015-38. PubMed ID: 25697708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alzheimer's pathology targets distinct memory networks in the ageing brain.
    Maass A; Berron D; Harrison TM; Adams JN; La Joie R; Baker S; Mellinger T; Bell RK; Swinnerton K; Inglis B; Rabinovici GD; Düzel E; Jagust WJ
    Brain; 2019 Aug; 142(8):2492-2509. PubMed ID: 31199481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alzheimer's disease-associated tau alters Drosophila circadian activity, sleep and clock neuron electrophysiology.
    Buhl E; Higham JP; Hodge JJL
    Neurobiol Dis; 2019 Oct; 130():104507. PubMed ID: 31207389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.